Hikma Pharma Announces Launch Of Morphine Sulfate Injection In The US

(RTTNews) - Hikma Pharmaceuticals has launched Morphine Sulfate Injection, USP, in 2mg/mL and 4mg/mL doses in the US. The product has been launched in a prefilled syringe form and is indicated for the management of pain severe enough to require an opioid analgesic and for which a https://www.nasdaq.com/articles/hikma-pharma-announces-launch-morphine-sulfate-injection-us